EcoDrugPlus

Phosphodiesterase 10a

Ensembl ID : ENSMMDG00005006902
Gene Symbol: PDE10A
3 Cross references
205 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSMMDG00005018698
Gene Symbol: PDE3A
1 Cross references
198 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSMMDG00005021704
Gene Symbol: PDE3A
1 Cross references
215 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSMMDG00005022591
Gene Symbol: PDE3B
3 Cross references
217 Possible Orthologues:

Phosphodiesterase 4a

Ensembl ID : ENSMMDG00005009519
Gene Symbol: PDE4A
1 Cross references
201 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSMMDG00005009518
Gene Symbol: PDE4B
1 Cross references
228 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSMMDG00005005822
Gene Symbol: PDE4D
3 Cross references
235 Possible Orthologues:

Phosphodiesterase 5a, Cgmp-Specific, B

Ensembl ID : ENSMMDG00005014454
Gene Symbol: PDE5AB
1 Cross references
222 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSMMDG00005002507
Gene Symbol: PDE7A
3 Cross references
180 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSMMDG00005006292
Gene Symbol: PDE7A
3 Cross references
227 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSMMDG00005006790
Gene Symbol: PDE7B
1 Cross references
189 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSMMDG00005003891
Gene Symbol: PDE9A
1 Cross references
184 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).